Population-based meta-analysis of furosemide pharmacokinetics. (Q54709391)

3 June 2018

meta-analysis

0 references

title

Population-based meta-analysis of furosemide pharmacokinetics. (English)

1 reference

3 June 2018

1 reference

1 reference

1

Scott A Van Wart

1 reference

3 June 2018

author name string

Susan E Shoaf

series ordinal

2

1 reference

3 June 2018

Suresh Mallikaarjun

series ordinal

3

1 reference

3 June 2018

Donald E Mager

series ordinal

4

1 reference

3 June 2018

publication date

16 November 2013

1 reference

3 June 2018

Biopharmaceutics and Drug Disposition

published in

1 reference

3 June 2018

volume

35

1 reference

3 June 2018

issue

2

1 reference

3 June 2018

page(s)

119-133

1 reference

3 June 2018

Natriuretic efficiency of frusemide as a consequence of drug input rate

cites work

1 reference

Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon

21 January 2018

1 reference

Biowaiver monographs for immediate release solid oral dosage forms: furosemide.

21 January 2018

1 reference

Comparison of furosemide and vinblastine secretion from cell lines overexpressing multidrug resistance protein (P-glycoprotein) and multidrug resistance-associated proteins (MRP1 and MRP2).

21 January 2018

1 reference

Resistance to loop diuretics. Why it happens and what to do about it.

21 January 2018

1 reference

Furosemide absorption in patients with cirrhosis.

21 January 2018

1 reference

The pharmacokinetics of frusemide are influenced by age.

21 January 2018

1 reference

Determinants of response to frusemide in normal subjects

21 January 2018

1 reference

A study on furosemide disposition in man.

21 January 2018

1 reference

Diuretic effect and diuretic efficiency after intravenous dosage of frusemide

21 January 2018

1 reference

The influence of co-administered organic acids on the kinetics and dynamics of frusemide

21 January 2018

1 reference

Effect of food on the absorption of frusemide and bumetanide in man.

21 January 2018

1 reference

The time of maximum effect for model selection in pharmacokinetic– pharmacodynamic analysis applied to frusemide

21 January 2018

1 reference

The influence of drug input rate on the development of tolerance to frusemide

21 January 2018

1 reference

The influence of frusemide formulation on diuretic effect and efficiency

21 January 2018

1 reference

Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers

21 January 2018

1 reference

Pharmacokinetic interaction of the direct renin inhibitor aliskiren with furosemide and extended-release isosorbide-5-mononitrate in healthy subjects

21 January 2018

1 reference

Furosemide pharmacokinetics and pharmacodynamics in renal transplantation

21 January 2018

1 reference

Comparison of loop diuretics in patients with chronic renal insufficiency

21 January 2018

1 reference

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

21 January 2018

1 reference

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

Ways to fit a PK model with some data below the quantification limit

21 January 2018

1 reference

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

21 January 2018

1 reference

Handling data below the limit of quantification in mixed effect models

21 January 2018

1 reference

Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation

21 January 2018

1 reference

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models

21 January 2018

1 reference

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

Meta-analysis of individual- and aggregate-level data.

21 January 2018

1 reference

Inter-study variability in population pharmacokinetic meta-analysis: when and how to estimate it?

21 January 2018

1 reference

Meta-analysis of longitudinal studies.

21 January 2018

1 reference

Meta-analysis of repeated measures study designs

21 January 2018

1 reference

Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials

21 January 2018

1 reference

Divergent biases in ecologic and individual-level studies

21 January 2018

1 reference

Ecological bias, confounding, and effect modification

21 January 2018

1 reference

Ecological effects in multi-level studies.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.1874

1 reference

3 June 2018

1 reference

3 June 2018